Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Tejani · SciRah

Researcher profile · Semantic Scholar

M. Tejani

Share profile

M. Tejani — researcher profile on SciRah

h-index: 29
Works: 115
Citations: 3,143

Most-cited papers

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
D. Catenacci, N. Tebbutt, I. Davidenko, A. Murad +17 more
2017The Lancet Oncology312 citations Open access
Semantic Scholar
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
J. Harding, Jia Fan, D. Oh, Hye Jin Choi +20 more
2023The Lancet Oncology214 citations Open access
Semantic Scholar
Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation
Christian P. Probst, A. Becerra, C. Aquina, M. Tejani +6 more
2015Journal of the American College of Surgeons183 citations Open access
Semantic Scholar
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
V. Chung, Shannon L. McDonough, P. Philip, D. Cardin +12 more
2017JAMA Oncology165 citations Open access
Semantic Scholar
Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study.
D. Cunningham, N. Tebbutt, I. Davidenko, A. Murad +15 more
2015141 citations
Semantic Scholar
The impact of age on complications, survival, and cause of death following colon cancer surgery
C. Aquina, S. Mohile, M. Tejani, A. Becerra +8 more
2016British Journal of Cancer125 citations Open access
Semantic Scholar
Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
M. Mohamed, A. Katz, M. Tejani, A. K. Sharma +7 more
2015Advances in Radiation Oncology116 citations Open access
Semantic Scholar
Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database
A. Becerra, Christian P. Probst, M. Tejani, C. Aquina +5 more
2016Annals of Surgical Oncology98 citations
Semantic Scholar
Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis
Zhao-Min Xu, S. Mohile, M. Tejani, A. Becerra +7 more
2017Cancer85 citations Open access
Semantic Scholar
Opportunities for cannabis in supportive care in cancer
A. Kleckner, I. Kleckner, C. Kamen, M. Tejani +3 more
2019Therapeutic Advances in Medical Oncology77 citations Open access
Semantic Scholar
Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase 3 study design.
D. Catenacci, Anteneh A. Tesfaye, M. Tejani, E. Cheung +7 more
2019Future Oncology68 citations Open access
Semantic Scholar
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
B. O'Neil, A. Scott, W.-W. Ma, S. Cohen +28 more
2015Annals of Oncology67 citations Open access
Semantic Scholar
Comparing Needles and Methods of Endoscopic Ultrasound-Guided Fine-Needle Biopsy to Optimize Specimen Quality and Diagnostic Accuracy for Patients with Pancreatic Masses in a Randomized Trial.
Young-Bang Ji, Konrad Krall, N. Jhala, C. Singh +5 more
2020Clinical Gastroenterology and Hepatology61 citations
Semantic Scholar
Relationships between personal attitudes about death and communication with terminally ill patients: How oncology clinicians grapple with mortality
Rachel A Rodenbach, Kyle E. Rodenbach, M. Tejani, R. Epstein
2015Patient Education and Counseling58 citations Open access
Semantic Scholar
Watch and Wait?—Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer
Christian P. Probst, A. Becerra, C. Aquina, M. Tejani +5 more
2015Journal of Gastrointestinal Surgery56 citations
Semantic Scholar
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Bert H. O'Neil, A. Scott, Wen W. Ma, Steven J. Cohen +28 more
2015Annals of Oncology56 citations Open access
Semantic Scholar
Associations of uncertainty with psychological health and quality of life in older adults with advanced cancer
H. Verduzco-Aguirre, D. Babu, S. Mohile, J. Bautista +14 more
2020Journal of Pain and Symptom Management52 citations Open access
Semantic Scholar
DETECTION OF CIRCULATING TUMOR DNA IN PLASMA: A POTENTIAL BIOMARKER FOR ESOPHAGEAL ADENOCARCINOMA
Matthew Egyud, M. Tejani, A. Pennathur, J. Luketich +13 more
2019Annals of Thoracic Surgery52 citations Open access
Semantic Scholar
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.
M. Tejani, Anna ter Veer, Dana Milne, Rebecca Ottesen +8 more
2014The Journal of the National Comprehensive Cancer Network46 citations Open access
Semantic Scholar
Practice Patterns for Organ Preservation in US Patients With Rectal Cancer, 2006-2020.
A. Loria, M. Tejani, Larissa K. F. Temple, Carla F. Justiniano +5 more
2023JAMA Oncology44 citations Open access
Semantic Scholar
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
G. Botta, M. Abdelrahim, Ronald Drengler, V. Aushev +24 more
2024The Oncologist42 citations Open access
Semantic Scholar
Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: An open-label feasibility study
J. Gewandter, Jenna Y. Chaudari, Chinazom Ibegbu, R. Kitt +7 more
2018Supportive Care in Cancer41 citations Open access
Semantic Scholar
Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
A. Becerra, Christian P. Probst, M. Tejani, C. Aquina +5 more
2015Surgery36 citations
Semantic Scholar
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish
S. Klempner, M. Sonbol, Z. Wainberg, H. Uronis +13 more
2024Journal of Clinical Oncology34 citations Open access
Semantic Scholar
Chemotherapy-induced peripheral neuropathy clinical trials
J. Gewandter, R. Freeman, R. Kitt, G. Cavaletti +8 more
2017Neurology34 citations Open access
Semantic Scholar
Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients
A. Becerra, C. Aquina, S. Mohile, M. Tejani +9 more
2017Annals of Surgical Oncology26 citations
Semantic Scholar
Symptom experiences in patients with advanced pancreatic cancer as reported during healthcare encounters
Chia-Chun Tang, C. Draucker, M. Tejani, D. Von Ah
2018European Journal of Cancer Care22 citations Open access
Semantic Scholar
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
G. Botta, M. Abdelrahim, V. Aushev, A. Esmail +13 more
2022Journal of Clinical Oncology18 citations
Semantic Scholar
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Bert H. O'Neil, A. Scott, W. Ma, Steven J. Cohen +27 more
2016Annals of Oncology16 citations Open access
Semantic Scholar
A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma
G. Abou-Alfa, R. Miksad, M. Tejani, S. Williamson +6 more
2018The Oncologist15 citations Open access
Semantic Scholar
The Influence of Patient Race and Activation on Pain Management in Advanced Lung Cancer: a Randomized Field Experiment
C. Shields, J. Griggs, K. Fiscella, Cezanne M. Elias +11 more
2019Journal of general internal medicine14 citations Open access
Semantic Scholar
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
G. Azzi, M. Tavallai, V. Aushev, A. Koyen Malashevich +8 more
2022The Oncologist13 citations Open access
Semantic Scholar
Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?
M. Cummings, K. Usuki, F. Fleming, M. Tejani +1 more
2019Journal of Gastrointestinal Oncology13 citations Open access
Semantic Scholar
The social and behavioral influences (SBI) study: study design and rationale for studying the effects of race and activation on cancer pain management
Cezanne M. Elias, C. Shields, J. Griggs, K. Fiscella +11 more
2017BMC Cancer12 citations Open access
Semantic Scholar
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer.
Stacey A. Cohen, V. Aushev, G. Laliotis, I. Jabbal +41 more
2025Annals of Surgery11 citations Open access
Semantic Scholar
Current Treatment Strategies for Elderly Patients with Metastatic Colon Cancer
Muhammad T. Idrees, M. Tejani
2019Cureus11 citations Open access
Semantic Scholar
Phase I results from the phase 1/3 FIGHT study evaluating bemarituzumab and mFOLFOX6 in advanced gastric/GEJ cancer (GC).
M. Tejani, E. Cheung, P. Eisenberg, A. Scott +8 more
2019Journal of Clinical Oncology11 citations
Semantic Scholar
Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base
A. Becerra, M. Berho, Christian P. Probst, C. Aquina +7 more
2016Annals of Surgical Oncology11 citations
Semantic Scholar
A phase 2 study (DisTinGuish) of DKN-01 in combination with tislelizumab + chemotherapy as first-line (1L) therapy in patients with advanced gastric or GEJ adenocarcinoma (GEA).
S. Klempner, B. Sonbol, Z. Wainberg, H. Uronis +11 more
2023Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers.
P. Kasi, G. Budde, F. Dayyani, G. Botta +12 more
20218 citations
Semantic Scholar
Patterns of interactions among patients with advanced pancreatic cancer, their caregivers, and healthcare providers during symptom discussions
Chia-Chun Tang, C. Draucker, M. Tejani, D. Von Ah
2018Supportive Care in Cancer8 citations
Semantic Scholar
Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC).
S. Pant, Jia Fan, D. Oh, H. Choi +16 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
1384P DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial
S. Klempner, C. Sirard, J. Chao, V. Chiu +13 more
2021Annals of Oncology7 citations Open access
Semantic Scholar
Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged ≥65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.
K. Shitara, T. Doi, H. Hosaka, P. Thuss-Patience +15 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
Da-Neng Li, S. Gruber, Shrividya Iyer, Sanjay Gupta +1 more
2023World Journal of Gastrointestinal Oncology5 citations Open access
Semantic Scholar
FIGHT: A phase 3 randomized, double-blind, placebo controlled study evaluating (bemarituzumab) FPA144 and modified FOLFOX6 (mFOLFOX6) in patients with previously untreated advanced gastric and gastroesophageal cancer with a dose finding phase 1 lead-in.
D. Catenacci, P. Enzinger, Anteneh A. Tesfaye, M. Tejani +7 more
20184 citations
Semantic Scholar
The role of myeloid derived suppressor cells in cholangiocarcinoma: A potential target for therapy.
R. Dunne, N. Figueroa, B. Belt, Jennifer J. Findeis-Hosey +9 more
20164 citations
Semantic Scholar
A dyadic exercise intervention to reduce psychological distress among lesbian, gay, bisexual, transgender, and heterosexual cancer survivors.
C. Kamen, L. Peppone, M. Janelsins, A. Peoples +4 more
20154 citations
Semantic Scholar
Pancreatic neuroendocrine tumors: does chemotherapy work?
M. Tejani, M. Saif
2014Journal of the Pancreas4 citations
Semantic Scholar
Treatment experiences and decision-making among patients with metastatic colorectal cancer: Results of an online US patient survey.
J. Clauer, Khadijah Ameen, Andrea Incudine, K. Newcomer +7 more
2025Journal of Clinical Oncology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Becerra×9
Invite
A. Becerra — researcher profile on SciRah
C. Aquina×9
Invite
C. Aquina — researcher profile on SciRah
F. Fleming×9
Invite
F. Fleming — researcher profile on SciRah
J. Monson×7
Invite
J. Monson — researcher profile on SciRah

×7

Invite

K. Noyes — researcher profile on SciRah

Christian P. Probst×6

Invite

Christian P. Probst — researcher profile on SciRah

Invite

S. Mohile — researcher profile on SciRah

Bradley J. Hensley×5

Invite

Bradley J. Hensley — researcher profile on SciRah

Invite

A. Scott — researcher profile on SciRah

Invite

V. Aushev — researcher profile on SciRah

Invite

Zhao-Min Xu — researcher profile on SciRah

Maynor G. González×4

Invite

Maynor G. González — researcher profile on SciRah